| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Baudax Bio, Inc. | Director | Common Stock | 41,656 | $106,123 | $2.55 | 15 Jun 2022 | Direct |
| Provention Bio, Inc. | Chief Financial Officer | Stock Option (right to buy) | 139,500 | 12 May 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000106299322015128-drechsler-andrew-t-2022-06-15 | Baudax Bio, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:12 |
| /report/000149315221011577-drechsler-andrew-t-2021-05-12 | Provention Bio, Inc. | 12 May 2021 | 1 | $0 | 4 | Chief Financial Officer | 14 May 2021, 19:37 |